Skip to main content
AmigoFish

Ben Bikman

Ben BikmanVideo

Format:
YouTube channel
New videos:
Weekly
Typical length:
about 25 minutes
Latest video:
Not rated yet

About this show

For years, as a scientist, my research has focused on the foundational role of metabolic health in controlling body weight and reducing the risk of chronic disease. Understanding how the interaction of calories and hormones affects our metabolic health has become the cornerstone of my work.

I’ve had the privilege of sharing this message with people across the globe, helping them understand the profound impact of their metabolic health on their lives. As a scientist I’m driven to uncover the science behind better health, to make that science accessible to everyone, and help other professionals do the same thing.

If you want to stay connected to the latest in metabolic science and health, I invite you to become an “Insider” at whatever level of participation works for you. You’ll gain access to exclusive research, insights and more.

I look forward to being better connected with you: BenBikman.com

Covers: metabolic health, nutrition science, insulin resistance, weight loss, hormones, glp-1 medications, blood sugar, diet and obesity

Videos come from the channel's public YouTube feed. The artwork is the newest video thumbnail. Last updated . Names, artwork and text belong to their publishers.

Recently on this show

Summary of recent videos, drawn from the publisher's feed.

This video channel, run by scientist Ben Bikman, explores how metabolic health, calories and hormones shape body weight and chronic disease risk. Recent videos cover fat tissue and hunger, GLP-1 medications and diet, potassium and blood sugar, regaining lost weight, and what glucose monitors miss.

Report a problem with this summary

Cosmos

Rated alike

Similar in subject

See the full Cosmos

Videos

  • 169: How Your Body Fat Can Make You Hungrier

    · 30 min

    Question? 📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Asprosin is a hormone released primarily by fat tissue that, according to animal research, increases hunger and tells the liver to release more glucose, especially during fasting. Higher asprosin levels have been associated with obesity and insulin resistance in humans, suggesting another way body fat may influence appetite and metabolic health. Summary: In this mini lecture, Dr. Ben Bikman introduces asprosin, a hormone released primarily by fat tissue that helps regulate both blood sugar and hunger. Unlike leptin, which generally signals the brain to reduce appetite, asprosin appears to do the opposite. During fasting, it tells the liver to release glucose into the bloodstream while also activating areas of the brain that encourage eating. These effects may be helpful when food is scarce, but could contribute to metabolic problems when the hormone remains elevated. Ben reviews research showing that asprosin levels are often higher in people with obesity, insulin resistance, and type 2 diabetes. Animal studies suggest that blocking asprosin can reduce hunger, lower blood glucose, and improve metabolic health. However, human research remains limited, and inconsistent laboratory measurements make it difficult to know exactly how much asprosin contributes to metabolic disease. He also compares asprosin with other appetite-related hormones, including ghrelin, leptin, and GLP-1, explaining how each sends different signals about hunger and energy availability. The central takeaway is that body fat is much more than a place to store calories. It is an active hormonal organ that communicates with the brain and liver, helping regulate how hungry we feel and how much glucose enters the bloodstream. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Timestamps (approximate): 01:10 — Why Body Fat Is More Than Stored Energy 03:00 — What Is Asprosin and Where Does It Come From? 05:45 — How Asprosin Raises Blood Sugar 09:45 — How Asprosin Signals the Brain to Increase Hunger 12:40 — The Genetic Discovery Behind Asprosin 15:35 — Asprosin, Obesity, and Insulin Resistance 17:20 — Why Measuring Asprosin Is So Difficult 20:40 — Asprosin vs. Ghrelin, Leptin, and GLP-1 24:00 — What Causes Asprosin Levels to Fall? 26:10 — Could Blocking Asprosin Treat Obesity? 28:10 — Final Takeaways: How Fat Controls Hunger and Glucose Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions. #Progesterone #MicronizedProgesterone #HormoneTherapy #Menopause #HRT #Estrogen #WomensHealth #MetabolicHealth…

    Not rated yet
  • 168: Why What You Eat Still Matters on GLP-1 Drugs

    · 21 min

    Questions? 📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: GLP-1 medications help reduce appetite, while low-carbohydrate diets help lower insulin and support fat burning, making them potentially complementary approaches to weight loss and metabolic health. Ben explains how combining low-dose medication with better food choices may help preserve muscle, improve metabolic markers, and build lasting habits that make it easier to maintain progress after treatment. Summary: In this mini lecture, Dr. Bikman explains why GLP-1 medications and low-carbohydrate diets may work better together than either approach alone. GLP-1 drugs help people feel less hungry and eat less, while reducing carbohydrates—especially refined sugars and starches—helps lower insulin and improve the body's ability to burn stored fat. Ben argues that these approaches address different parts of the same metabolic problem. He reviews research from his own lab involving patients who combined low-dose semaglutide with a whole-food ketogenic diet and Insulin IQ coaching. Over six months, participants lost an average of approximately 22 kilograms (nearly 50 pounds), with an estimated 92% of that weight loss coming from fat. The study also found improvements in fasting insulin and several metabolic health markers, although Ben emphasizes that the results are preliminary because the study was small and lacked a control group. Ben also explores how ketones may help protect muscle, how food choices might influence medication side effects and gallbladder health, and why weight frequently returns after GLP-1 treatment ends. His central message is that these medications should be used as an opportunity to develop healthier habits, not simply as a way to eat smaller portions of the same foods. By using the lowest effective dose, emphasizing protein and natural fats, reducing refined carbohydrates, and maintaining regular exercise, people may be better positioned to sustain their progress and eventually reduce their reliance on medication with medical supervision. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Timestamps (approximate): 01:49 — Are GLP-1 Medications and Diet Competing Strategies? 03:12 — How GLP-1 Drugs Reduce Appetite 04:26 — Why Lowering Carbohydrates Changes Insulin 05:10 — The Connection Between Insulin Resistance and Natural GLP-1 07:01 — Using GLP-1 Medication to Change Food Cravings 09:20 — Ben's Research: Low-Dose Semaglutide Plus Keto 11:34 — Can Ketones Help Protect Muscle During Weight Loss? 13:45 — GLP-1 Side Effects and the Role of Food Choices 14:51 — Gallbladder Health and Dietary Fat 16:23 — Why Weight Often Returns After Stopping GLP-1 Drugs 18:45 — Why Traditional GLP-1 Treatment May Miss the Bigger Picture 19:45 — Building Habits and Planning an Exit From GLP-1 Medication Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) NOTE: The…

    Not rated yet
  • 167: Could Low Potassium Be Raising Your Blood Sugar?

    · 29 min

    Questions? 📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Potassium and insulin have a two-way relationship: insulin moves potassium into cells, while low potassium can interfere with the pancreas's ability to release insulin and maintain healthy blood sugar. Ben explains how aldosterone, fasting, and carbohydrate intake affect this balance, emphasizing the importance of potassium-rich foods and safely ending prolonged fasts. Summary: Dr. Ben Bikman explains the surprising relationship between potassium, insulin, and blood sugar control. Potassium is an essential mineral that helps cells maintain their electrical activity, and insulin plays an important role in moving potassium from the bloodstream into cells. But the relationship works both ways: when potassium levels become too low, the pancreas may struggle to release enough insulin, potentially causing blood sugar to rise. Ben also explores the role of aldosterone, a hormone that tells the kidneys to retain sodium while releasing potassium. When aldosterone levels are too high, potassium loss can increase, insulin production may suffer, and blood pressure can rise. He reviews research linking lower potassium levels—even within the normal laboratory range—to an increased risk of developing type 2 diabetes. The lecture then examines what happens during fasting and carbohydrate restriction. As insulin falls, the kidneys release more sodium and water, while changes in aldosterone can increase potassium loss. Ben explains why this matters especially when ending a prolonged fast: a sudden insulin spike from a carbohydrate-heavy meal can rapidly move potassium into cells, potentially causing dangerous electrolyte imbalances. The central takeaway is that potassium deserves more attention in metabolic health. Eating potassium-rich whole foods, maintaining appropriate electrolyte balance, and being thoughtful about how prolonged fasts are ended may help support healthy insulin function and blood sugar regulation. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Timestamps (approximate): 01:11 — Why Potassium Matters for Insulin 03:09 — How Insulin Moves Potassium Into Cells 05:30 — Why Low Potassium Can Reduce Insulin Production 07:58 — Aldosterone: The Other Hormone Controlling Potassium 10:34 — Blood Pressure Medications and Potassium Loss 11:44 — Excess Aldosterone, Diabetes, and Insulin Resistance 15:15 — Dietary Potassium and Metabolic Health 16:18 — What Your Blood Potassium Test Really Tells You 18:20 — How Fasting Changes Potassium and Electrolytes 21:28 — The Danger of Refeeding After a Long Fast 25:22 — How to Safely Break a Prolonged Fast 27:10 — Final Takeaways: Potassium, Insulin, and Blood Sugar Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or…

    Not rated yet
  • 166: Why Your Body Fights to Regain Lost Weight

    · 26 min

    Question? 📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: After significant weight loss, the body can respond by increasing hunger and slowing metabolism beyond what would be expected from having a smaller body. Ben explains how lowering insulin, preserving muscle, eating sufficient protein, and staying active may help minimize this metabolic slowdown and make long-term weight maintenance easier. Summary: Dr. Bikman explains why losing a large amount of weight can sometimes cause the body's metabolism to slow down more than expected. He uses contestants from The Biggest Loser as an example. Six years after their dramatic weight loss, many had regained much of the weight, yet their bodies were still burning approximately 500 fewer calories per day than expected for their size. This phenomenon is called metabolic adaptation. Ben explains how hormones such as leptin, insulin, and thyroid hormone influence this process. As body fat decreases, leptin falls, signaling the brain to increase hunger and conserve energy. The body may also reduce spontaneous movement and other energy-consuming activities, making it increasingly difficult to maintain weight loss. The encouraging news is that the way someone loses weight can make a difference. Ben reviews research suggesting that lower-carbohydrate diets may help preserve energy expenditure after weight loss, particularly in people who produce more insulin. He also emphasizes the importance of eating sufficient protein, maintaining muscle through resistance training, and staying physically active throughout the day. The central takeaway is that successful weight loss isn't just about losing pounds—it's about protecting your metabolism and developing habits that make the new weight easier to maintain. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Timestamps (approximate): 00:00 — The Biggest Loser Effect: Why Metabolism Slows 01:10 — What Really Determines Your Metabolic Rate? 02:39 — Metabolic Adaptation Explained 03:51 — What Happened to The Biggest Loser Contestants? 05:30 — Six Years Later: Burning 500 Fewer Calories Daily 07:54 — How Leptin Drives Hunger and Metabolic Slowdown 10:06 — Thyroid Hormones and Energy Conservation 11:16 — Why We Unconsciously Move Less After Weight Loss 12:57 — Extreme Calorie Restriction vs. Preserving Muscle 14:13 — How to Reduce Metabolic Adaptation 16:30 — Why Burning Fat Instead of Sugar Matters 18:38 — Low-Carb Diets and Higher Energy Expenditure 21:57 — How to Restore and Maintain Metabolic Health 25:07 — Final Takeaways: Protecting Your Metabolism Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers…

    Not rated yet
  • 165: Why Micronized Progesterone Is Different

    · 24 min

    Question? 📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Micronized progesterone is chemically identical to the progesterone naturally produced by the ovaries and appears metabolically different from many synthetic progestins. When paired with estrogen, it can protect the uterus while preserving estrogen’s metabolic benefits and may also improve sleep, hot flashes, and overall tolerability. Summary: Dr. Bikman explains why micronized progesterone should not be confused with the synthetic progestins historically used in many hormone therapies. Micronized progesterone is chemically identical to the hormone produced naturally by a woman’s ovaries, while synthetic progestins can also activate cortisol- or testosterone-related receptors, potentially affecting insulin sensitivity, blood lipids, and other aspects of metabolic health. Ben reviews clinical evidence showing that micronized progesterone can effectively protect the uterine lining when estrogen is used while preserving more of estrogen’s favorable metabolic effects. Oral micronized progesterone is also converted into allopregnanolone, which enhances the brain’s calming GABA signaling and may improve sleep. Better sleep itself can support insulin sensitivity, while progesterone may also reduce hot flashes and night sweats that interfere with sleep. The safety evidence is also encouraging. Compared with some synthetic progestins, micronized progesterone appears more favorable with respect to blood clots, breast cancer risk, and metabolic markers. Ben’s overall conclusion is that for women using menopausal hormone therapy who need progesterone to protect the uterus, micronized progesterone appears to be a metabolically favorable partner to estrogen. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Timestamps (approximate): 01:00 — Micronized Progesterone vs. Synthetic Progestins 02:05 — What Progesterone Does in a Woman’s Body 05:08 — Why Synthetic Progestins Are Different 06:34 — Oral vs. Vaginal Progesterone 08:26 — How Synthetic Progestins Can Affect Metabolic Health 10:43 — Progesterone, Estrogen, and Insulin Sensitivity 12:05 — Does Micronized Progesterone Protect the Uterus? 16:42 — Why Progesterone Can Improve Sleep 18:50 — Blood Clots and Hormone Therapy 20:03 — Progesterone and Breast Cancer Risk 22:08 — Estrogen, Progesterone, and Insulin Resistance 23:21 — Final Takeaway: Why the Type of Progesterone Matters Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions. #Progesterone #MicronizedProgesterone #HormoneTherapy #Menopause #HRT #Estrogen #WomensHealth…

    Not rated yet
  • 164: Can Your Body Make More GLP-1 Naturally?

    · 26 min

    Question? 📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Chronically elevated insulin may make the intestinal cells that produce GLP-1 insulin resistant, weakening the body's natural satiety response—particularly after carbohydrate-rich foods. Ben argues that GLP-1 medications can provide a temporary window to control carbohydrate cravings, lower insulin, rebuild metabolic habits, and ultimately work toward needing less medication rather than automatically remaining on a high dose indefinitely. Summary: Dr. Bikman explains why some people may produce an inadequate GLP-1 response and how insulin resistance could be part of the problem. Because intestinal L cells have insulin receptors, chronically elevated insulin can make these cells insulin resistant, reducing their ability to release GLP-1 and potentially creating a cycle of faster stomach emptying, higher glucose, more insulin, and further impairment of the natural GLP-1 response. Ben uses this physiology to explain how he believes GLP-1 medications should be used: not simply to produce maximum weight loss, but as a temporary window in which carbohydrate cravings become easier to control. Rather than escalating automatically to the highest tolerated dose, he favors using the lowest dose that makes refined carbohydrates easier to resist while still requiring the person to exercise some choice and discipline. During that window, the goal is to establish meals centered on protein, healthy fats, and whole foods while improving sleep and resistance training. Ben also addresses concerns about lean-mass loss, explaining that body-composition scans can classify losses of water, glycogen, organ fat, and even the non-fat portion of adipose tissue as “lean mass.” Ultimately, he argues that GLP-1 therapy should have an exit strategy: improve insulin sensitivity, restore the body's own GLP-1 signaling as much as possible, establish sustainable habits, and then work with a clinician to gradually reduce the medication rather than assuming it must be permanent. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Timestamps (approximate): 02:03 — What GLP-1 Does After a Meal 04:17 — The Surprising GLP-1 Response to Carbohydrates 05:57 — Why Insulin Resistance May Silence the L Cell 09:31 — The Vicious Cycle of Insulin Resistance and Low GLP-1 11:53 — Using GLP-1 Medication as a Window 12:48 — Why the Craving Benefit May Fade Over Time 14:44 — Why Higher GLP-1 Doses Aren’t Always Better 17:01 — Building Your Own “Mental Muscle” 18:35 — Does GLP-1 Therapy Really Cause Muscle Loss? 21:54 — Why Weight Often Returns After Stopping GLP-1 Drugs 24:14 — Building an Exit Strategy From GLP-1 Medication 26:22 — Final Takeaway: The Goal Is to Need Less Help Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) NOTE: The information presented is not intended to be a substitute for professional medical…

    Not rated yet
  • 163: What Your Glucose Monitor Is Missing

    · 30 min

    Question? 📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Continuous glucose monitoring shows how the body handles glucose, but it cannot reveal how much insulin was required to produce that glucose response. By continuously measuring ketones alongside glucose, the new dual sensor may provide an indirect window into insulin activity, fat burning, and metabolic flexibility while also helping people with diabetes detect dangerous ketone elevations earlier. Summary: Dr. Ben Bikman explores a new wearable that continuously measures both glucose and ketones. Unlike a traditional continuous glucose monitor, Abbott’s Libre Duo can track beta-hydroxybutyrate (BHB) alongside glucose, providing another window into what is happening metabolically. For people with diabetes, continuous ketone monitoring could provide earlier warning of dangerous ketoacidosis, particularly in people with type 1 diabetes or those using SGLT2 inhibitors. Ben explains why ketones provide information that glucose alone cannot. Because insulin strongly suppresses fat release, fat oxidation, and ketone production, changes in ketones can serve as an indirect indicator of insulin activity. A seemingly normal glucose response can therefore hide the fact that the body required a large amount of insulin to produce it, while watching glucose and ketones together may reveal more about how readily the body transitions between glucose and fat metabolism. Ben sees potential value beyond diabetes as well. During fasting or carbohydrate restriction, glucose would generally fall while ketones rise; after a carbohydrate-rich meal, the opposite occurs. Tracking both signals continuously could therefore offer a more complete picture of metabolic flexibility and help people better understand their individual responses to food, fasting, and other metabolic changes. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Timestamps (approximate): 00:01 — The First Sensor to Continuously Track Glucose and Ketones 01:03 — What the New Libre Duo Actually Measures 03:17 — Why Continuous Ketone Monitoring Matters for Diabetes 04:33 — The Three Ketones and What Each Test Measures 06:31 — Why Blood, Urine, and Breath Ketone Tests Have Limitations 10:05 — What We Learned From Continuous Glucose Monitoring 11:08 — How Insulin Controls Ketone Production 16:55 — Nutritional Ketosis vs. Diabetic Ketoacidosis 19:28 — When Are Ketones Actually Too High? 21:37 — Why Glucose Alone Can Be Misleading 23:53 — Measuring Ketones in Interstitial Fluid vs. Blood 26:57 — What Glucose and Ketones Together Can Tell You 29:59 — Final Takeaway: A More Complete Picture of Metabolic Health Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your…

    Not rated yet
  • 162: The New GLP-1 Pills & What You Need to Know

    · 25 min

    Question? 📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: New oral GLP-1 drugs can make treatment more convenient, but oral semaglutide and the small-molecule drug orforglipron reach the bloodstream in very different ways. Ben argues that regardless of delivery method, these medications are most valuable when used as a temporary tool to control carbohydrate cravings, lower insulin, and build habits that can ultimately reduce reliance on the drug. Summary: In today’s mini-lecture, Dr. Ben Bikman explains the new generation of oral GLP-1 medications and why two drugs that come as pills can work very differently. Oral semaglutide is still a peptide, so it requires a special absorption enhancer to protect it from digestion and help it cross the stomach lining. Even then, only about 1% of the dose reaches the bloodstream, requiring strict instructions about taking it on an empty stomach. Orforglipron, by contrast, is a small molecule rather than a peptide, allowing it to survive digestion and be absorbed much more efficiently without the same restrictions. Ben reviews studies comparing the drugs for blood glucose control, weight loss, side effects, and maintaining weight loss after injectable GLP-1 therapy. But he emphasizes that changing the delivery method does not change the underlying metabolic rules: insulin still governs whether fat is stored or released. Most importantly, Ben argues that GLP-1 medications should be viewed as an opportunity to change metabolic habits rather than simply as long-term weight-loss drugs. Because they can temporarily reduce cravings for sweets and refined carbohydrates, he believes that window should be used to reduce those foods, emphasize protein and fat, and develop habits that can eventually provide an “off-ramp” from the medication.. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Timestamps (approximate): 00:20 — Are GLP-1 Pills Just Injections in Tablet Form? 02:16 — What GLP-1 Actually Does 04:34 — Why Peptide Drugs Usually Need a Needle 05:47 — How Oral Semaglutide Survives the Stomach 08:42 — Why Oral Semaglutide Has Strict Dosing Rules 09:41 — Orforglipron: A Completely Different Kind of GLP-1 Drug 12:31 — What the Oral GLP-1 Studies Show 15:43 — Weight Loss, Side Effects, and Real-World Convenience 16:59 — Switching From GLP-1 Injections to a Pill 17:54 — The Metabolic Rule the Drugs Cannot Change 21:04 — The Window to Change Your Carbohydrate Cravings 23:11 — Using GLP-1 Drugs as a “Crutch,” Not Forever 24:54 — Final Takeaway: The Drug Changes, the Metabolic Rules Don’t Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions…

    Not rated yet
  • 161: Why Your Body Chooses Sugar Over Fat

    · 32 min

    Question? 📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Insulin is one of the body’s most important signals for determining whether you burn glucose or fat: when insulin rises, fat release and fat burning fall, while lower insulin allows stored fat to become available for fuel. This helps explain why reducing carbohydrates can dramatically increase fat oxidation even without changing the body’s basic ability to burn fat. Summary: In this mini-lecture Ben explains what determines whether the body burns glucose or fat for energy. He begins with the Randle cycle, also called the glucose-fatty acid cycle, which describes how these two fuels compete with one another. But Ben emphasizes that simply having fat available does not mean the body will burn it. Insulin plays a major role in deciding which fuel gets used. When insulin rises after eating carbohydrates, it suppresses the release of stored fat from fat cells and also makes it harder for long-chain fatty acids to enter the mitochondria to be burned. As a result, the body shifts toward burning glucose. When insulin falls, stored fat becomes available again and can more readily enter the mitochondria for energy. Ben reviews human studies showing that carbohydrate restriction can dramatically increase fat oxidation, including research in endurance athletes who became highly efficient fat burners without sacrificing performance or muscle glycogen. He also explains what happens with insulin resistance: insulin can remain high enough to block fat burning in muscle while insulin-resistant fat cells continue releasing fatty acids, creating a metabolic mismatch that promotes fat accumulation in places such as the liver and muscle. The central takeaway is that fuel selection is not simply about calories or which fuel happens to be available. Insulin strongly regulates whether stored fat can be released and burned, which is why lowering carbohydrate intake can dramatically increase the body’s ability to use fat for fuel. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Timestamps (approximate): 01:40 — The Randle Cycle: How Glucose and Fat Compete 05:08 — Human Evidence That Fat Burning Reduces Glucose Burning 09:11 — Does Glucose Also Shut Down Fat Burning? 12:51 — How Insulin Blocks Fat Burning 18:19 — What Happens When You Keep Insulin Elevated 20:29 — Low-Carb Diets Dramatically Increase Fat Oxidation 22:43 — Insulin Resistance and “Metabolic Inflexibility” 26:45 — Does Burning More Fat Lead to More Fat Loss? 30:12 — What Happens When Calories Are Increased Instead of Cut? 32:08 — The Bottom Line: Insulin Decides Which Fuel You Burn Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek…

    Not rated yet
  • 160: The Biggest Myth About Mitochondrial Health

    · 38 min

    Question? 📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Mitochondria often struggle in insulin resistance not because they are broken, but because there are fewer of them trying to process too much incoming fuel. Exercise and improved metabolic health remain the most effective ways to build healthier mitochondria, while supplements may provide additional—but smaller—benefits. Summary: In this mini-lecture, Ben explains why mitochondria have become one of the most talked-about topics in health while separating scientific evidence from popular hype. He begins by reviewing how mitochondria convert the energy stored in carbohydrates, fats, and ketones into ATP, the usable energy that powers virtually every function in the body. Along the way, he explains concepts such as glycolysis, the Krebs cycle, the electron transport system, coupling versus uncoupling, and the production of reactive oxygen species. Ben then examines what happens in insulin resistance and type 2 diabetes. Rather than concluding that mitochondria are "broken," he explains that the evidence points to a different problem: people with insulin resistance generally have fewer mitochondria, more fragmented mitochondrial networks, and an excessive fuel load. As glucose and fatty acids arrive faster than the mitochondria can process them, byproducts such as lactate and acylcarnitines begin to accumulate, signaling a mismatch between fuel supply and mitochondrial capacity. The lecture also reviews current approaches to measuring mitochondrial health, including fasting lactate, the lactate-to-pyruvate ratio, and newer biomarkers such as GDF15 and FGF21. Dr. Bikman discusses several popular mitochondrial interventions—including methylene blue, urolithin A, CoQ10, red-light therapy, and cold exposure—highlighting where human evidence is promising and where it remains limited. The central message is that no supplement outperforms the fundamentals. Exercise consistently increases mitochondrial number and function while improving insulin sensitivity, and lowering carbohydrate intake reduces the fuel burden placed on mitochondria. Together, these strategies address the root problem more effectively than relying on supplements alone. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Timestamps (approximate): 00:00 — Intro: Why Mitochondria Matter 02:10 — How Cells Turn Food Into Energy 07:22 — The Electron Transport System Explained 13:58 — What Happens to Mitochondria in Insulin Resistance 19:39 — Lactate: A Window Into Mitochondrial Health 23:47 — Can We Measure Mitochondrial Function? 27:50 — Do Mitochondrial Supplements Actually Work? 34:40 — Why Exercise Is the Best Mitochondrial Therapy 35:54 — Ketones, Mitochondria, and Ben's Research 38:09 — Final Takeaways: Build More Mitochondria, Don't Just Boost Them Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) NOTE:…

    Not rated yet
  • 159: Why Exercise Alone Won’t Help You Lose Weight

    · 23 min

    📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Exercise is not a very reliable tool for losing weight because the body adapts by conserving energy and sometimes increasing hunger. Its greatest benefits are improving insulin sensitivity, building strength, reducing visceral fat, and helping you live a longer, healthier life. Summary: Dr. Bikman challenges one of the most common beliefs about exercise—that its primary purpose is to help people lose weight. While exercise certainly burns calories, he explains that the body quickly adapts by reducing energy expenditure elsewhere and, in many people, increasing appetite. As a result, the amount of weight lost is often much less than simple calorie calculations would predict. Ben explains that these adaptations do not mean exercise is ineffective. Instead, they reveal that body weight is the wrong outcome to focus on. Exercise dramatically improves insulin sensitivity, allowing contracting muscles to pull glucose out of the bloodstream without requiring insulin. It also increases the number of glucose transporters in muscle, improves mitochondrial function, reduces dangerous visceral fat, and helps preserve or build muscle mass. The lecture concludes by emphasizing that the greatest benefits of exercise have little to do with the number on the scale. Strength, fitness, muscle mass, and insulin sensitivity are all far better predictors of long-term health and longevity. Dr. Bikman’s message is simple: exercise to become stronger and healthier, and eat wisely if your goal is to become leaner. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Timestamps (approximate): 00:00 — Why Exercise Isn't a Great Weight-Loss Tool 02:22 — Why the Calorie Math Stops Working 04:44 — The Body Compensates by Burning Less Energy 07:53 — Why We Also Move Less After Exercise 09:46 — Does Exercise Make You Hungrier? 13:41 — Exercise Improves Insulin Sensitivity Without More Insulin 15:52 — Why Muscle Matters More Than Body Weight 19:05 — Exercise Reduces Dangerous Visceral Fat 20:05 — Ben's Exercise Prescription: Train for Strength 22:02 — What You Should Measure Instead of Body Weight 23:00 — Final Takeaway: "Exercise to Be Strong, Eat Smart to Be Lean" Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions. #Exercise #WeightLoss #StrengthTraining #InsulinSensitivity #MetabolicHealth #Muscle #VisceralFat #Fitness #Longevity #ResistanceTraining #BloodSugar #Glucose #InsulinResistance #HealthyAging #Metabolism #DrBenBikman #MetabolicClassroom #ExerciseScience #MuscleHealth #HealthScience Ben’s favorite…

    Not rated yet
  • 158: Why Some People Stay Thin No Matter What They Eat

    · 29 min

    📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Some people stay lean because they burn more fat in muscle, move more without realizing it, or naturally expend more energy throughout the day. Others only appear lean because they store fat inside the liver and around the organs, making metabolic health far more important than appearance alone. Summary: Dr. Bikman explores a common question: Why do some people seem to eat whatever they want and never gain weight? He explains that there isn't one simple answer. Instead, several different metabolic processes can produce the same outward appearance of being lean, even though the underlying health may be very different. The first explanation is fuel partitioning. After a meal, dietary fat can either be stored in fat tissue or burned by muscle. Which tissue "claims" that fat is heavily influenced by the enzyme lipoprotein lipase (LPL), whose activity is regulated by insulin. People whose muscles are better at taking up and burning fat tend to store less of it. Exercise training also shifts LPL activity toward muscle, while inactivity shifts it back toward fat storage. A second explanation is that some people unconsciously burn off excess calories through everyday movement. Research shows that fidgeting, standing, pacing, and other non-exercise activity can account for hundreds of calories each day, creating enormous differences in fat gain between people eating similar amounts of food. Genetics also appear to influence these natural tendencies. Finally, Dr. Bikman explains that some lean people are not avoiding fat storage at all—they're simply storing fat where it can't be seen. Instead of accumulating under the skin, fat may build up around the organs or inside the liver, pancreas, and muscle, increasing metabolic risk despite a normal body weight. The takeaway is that appearance alone cannot determine metabolic health. Blood markers such as fasting insulin and the triglyceride-to-HDL ratio provide a much better picture than body weight or BMI alone. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Timestamps (approximate): 00:00 — Intro Hook: Why Some People Never Gain Weight 01:18 — Three Reasons Some People Stay Lean 04:16 — LPL: The Enzyme That Decides Where Fat Goes 07:42 — Exercise Changes Fat Storage vs. Fat Burning 11:12 — Why Some People Burn More Calories Without Trying 15:42 — How Genetics Influence Weight Gain 19:06 — The "Thin Outside, Fat Inside" Phenomenon 22:02 — Personal Fat Threshold Explained 24:51 — Fat Cell Size, Ectopic Fat, and Diabetes Risk 27:46 — Final Takeaways: Why Appearance Can Be Misleading Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice…

    Not rated yet
  • 157: Why You're Always Hungry (Even After Eating)

    · 23 min

    📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Persistent hunger can result when high insulin lowers circulating fuel while the brain becomes resistant to important fullness signals from insulin and leptin. Restoring insulin sensitivity and avoiding repeated large glucose and insulin spikes may help correct the signals driving hunger rather than relying on willpower alone. Summary: Dr. Ben Bikman explains why constant hunger is often driven by hormones rather than a lack of willpower. He begins by showing how meals high in rapidly digested carbohydrates can trigger large insulin spikes, causing fuel to move quickly out of the bloodstream and into storage. Even though the body has plenty of stored energy, the brain senses that available fuel has dropped and responds by making you feel hungry again. Ben then explores three key hormones that regulate fullness: GLP-1, leptin, and insulin. Some people produce less GLP-1 after carbohydrate-rich meals, while others become resistant to leptin and insulin in the brain, weakening the signals that normally reduce appetite and cravings. The takeaway is that persistent hunger is often a signaling problem rather than simply a discipline problem. By lowering chronic insulin levels and improving insulin sensitivity, the body's natural hunger and fullness signals can begin working the way they were designed to. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Timestamps (approximate): 00:01 — Intro Hook: Why You’re Hungry Again 00:48 — Hunger Is More Than Willpower 01:48 — How Insulin Changes Fuel Availability 04:00 — High-Carb Meals and the Reactive Energy Dip 05:06 — Why High-Glycemic Meals Lead to More Eating 07:29 — Falling Blood Glucose as a Hunger Signal 08:31 — The Cycle of Carb Cravings and Hunger 10:12 — GLP-1 and the Fullness Response 13:18 — Leptin: The Signal From Stored Body Fat 15:25 — Leptin Resistance and Persistent Hunger 16:39 — Insulin as a Satiety Signal in the Brain 19:00 — Brain Insulin Resistance and Food Cravings 21:10 — The Four Hormonal Drivers of Constant Hunger 23:32 — Final Takeaway: Correct the Metabolic Signals Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions. #Hunger #InsulinResistance #Insulin #LeptinResistance #GLP1 #FoodCravings #AppetiteControl #BloodSugar #MetabolicHealth #ReactiveHypoglycemia #CarbCravings #Satiety #BrainInsulinResistance #HighGlycemicFoods #BloodSugarSpikes #LowCarbScience #DrBenBikman #MetabolicClassroom #MetabolismMatters #HealthScience Ben’s favorite yerba mate and fiber: https://ufeelgreat.com/usa/en/c/1BA884 Exogenous…

    Not rated yet
  • 156: The Most Dangerous Fat in Your Body

    · 23 min

    📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Visceral fat is dangerous because it sits deep around the organs and drains directly to the liver, sending fatty acids and inflammatory signals where they can drive fatty liver, insulin resistance, and systemic inflammation. The good news is that visceral fat responds strongly to exercise-related catecholamines, making physical activity one of the best tools for reducing it. Summary: In this lecture, Dr. Ben Bikman explains why visceral fat is one of the most metabolically dangerous forms of body fat. Unlike subcutaneous fat, which sits under the skin and can be pinched, visceral fat is stored deep inside the abdomen around the organs. Its location matters because visceral fat drains directly into the liver through the portal vein, meaning the fatty acids and inflammatory signals it releases reach the liver first and at high concentration. Dr. Bikman explains that visceral fat is especially harmful because it tends to grow through hypertrophy, meaning existing fat cells get larger rather than new smaller fat cells being created. As these fat cells enlarge, they become insulin resistant and begin leaking fatty acids even when insulin should be suppressing fat release. Those fatty acids can then accumulate in the liver, pancreas, and muscle, contributing to ectopic fat storage, fatty liver disease, and worsening insulin resistance. The lecture also highlights how enlarged visceral fat cells can become hypoxic, or oxygen-starved, which pushes them to release inflammatory signals and recruit immune cells. This turns visceral fat into an active source of chronic low-grade inflammation. The hopeful takeaway is that visceral fat is also highly responsive to catecholamines, the hormones released during physical activity. Exercise can therefore help reduce visceral fat specifically, even when overall body weight does not change dramatically. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) Timestamps (approximate): 00:05 — What Makes Visceral Fat Different? 02:08 — Why Visceral Fat Damages the Liver First 04:36 — Why Men and Women Store Fat Differently 07:04 — How Visceral Fat Becomes Metabolically Dangerous 09:31 — Insulin Resistance, Fat Leakage, and Fatty Liver 13:20 — Hypoxia, Inflammation, and Immune Cell Invasion 18:00 — Why Visceral Fat Responds So Well to Exercise 21:29 — Could Cold Exposure Reduce Visceral Fat? 22:41 — Final Takeaways: Why Visceral Fat Is Different NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions. #VisceralFat #InsulinResistance #FattyLiver #MetabolicHealth…

    Not rated yet
  • 155: Why Your Bones Affect Your Metabolism

    · 21 min

    📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Bone is a metabolically active organ that responds to insulin and glucose while releasing hormones that influence the pancreas, fat cells, appetite, and energy use. High glucose and insulin resistance can make bones brittle despite normal density, while resistance training, stable glucose, and good nutrition support both skeletal and metabolic health. Summary: Dr. Bikman explains why bone should be understood as a metabolic organ, not just structural scaffolding. Bone is living tissue that is constantly being broken down and rebuilt by opposing teams of cells, and that remodeling process requires energy, nutrients, and hormonal coordination. Far from being inert, bone responds to metabolic signals such as insulin, glucose, and leptin—and it sends signals back to the rest of the body. Ben focuses first on insulin’s role in bone health. Insulin acts as a growth signal for bone-building cells, helping maintain bone density and structure. In type 1 diabetes, where insulin is absent, bone density and architecture suffer. In type 2 diabetes, the problem is different: bone density may look normal on a DEXA scan, but chronically high glucose can glycate collagen, making bone stiffer and more brittle. At the same time, insulin resistance weakens the bone-building signal, creating the “diabetic bone paradox,” where bones appear dense but fracture more easily. The lecture then explores bone-derived hormones, especially osteocalcin and lipocalin-2. Osteocalcin can support insulin secretion under glucose stimulation, increase adiponectin from fat cells, improve insulin sensitivity, reduce inflammation, and promote fat burning. Lipocalin-2 travels from bone to the brain after meals and appears to help suppress appetite while also supporting glucose regulation. The practical takeaway is that metabolic health and bone health are deeply connected: stable glucose, good insulin sensitivity, vitamin K, resistance training, and weight-bearing movement all help protect the skeleton and support whole-body metabolism. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) Timestamps (approximate): 01:07 — Introduction: Bone as a Metabolic Organ 02:08 — Bone Is Living, Remodeling Tissue 03:21 — Leptin, Fat, and Bone Signaling 04:24 — Insulin as a Bone-Building Signal 06:27 — Type 1 Diabetes and Bone Loss 07:29 — The Diabetic Bone Paradox 08:41 — Glucose, Glycation, and Brittle Bone 09:47 — Insulin Resistance and Suppressed Bone Turnover 11:51 — Bone Resorption and Osteocalcin Activation 12:59 — Osteocalcin as a Metabolic Hormone 15:10 — Osteocalcin, Adiponectin, and Fat Burning 17:21 — Lipocalin-2: Bone’s Appetite Signal 19:31 — The Pancreas-Bone-Fat Feedback Loop 20:38 — Resistance Training, Vitamin K, and Low-Carb Nutrition NOTE: The information…

    Not rated yet
  • 154: Why Some People Burn More Calories Than Others

    · 28 min

    📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Mitochondrial uncoupling allows cells to burn fuel while releasing more of that energy as heat instead of capturing it as ATP. Insulin appears to make fat-cell mitochondria more efficient and storage-oriented, while low insulin and elevated ketones may push fat tissue toward greater energy waste and easier fat loss. Summary: In this Metabolic Classroom episode, Dr. Bikman explains mitochondrial uncoupling, a process where cells burn fuel without converting all of that energy into usable ATP. Normally, mitochondria are “coupled,” meaning fuel burning is efficiently converted into cellular energy. But when mitochondria become uncoupled, some of that fuel is released as heat instead—like revving a car engine while it’s in park. Ben explains that this process is especially important in fat tissue. White fat is designed for energy storage and tends to be tightly coupled, while brown fat is rich in mitochondria and uncoupling proteins that burn fuel to generate heat. He then connects this physiology to insulin, showing that insulin appears to make fat-cell mitochondria more tightly coupled and efficient, lowering energy expenditure and making storage easier. The opposite happens when insulin is low and ketones rise. Research from Dr. Bikman’s lab shows that ketones, especially beta-hydroxybutyrate, can increase mitochondrial respiration in fat cells without a matching rise in ATP production—clear evidence of uncoupling. In human fat biopsies, elevated ketones were associated with markedly higher mitochondrial respiration, suggesting that ketosis can make fat tissue more wasteful with energy. The larger takeaway is that calories still matter, but hormones influence how efficiently those calories are stored or burned. When insulin is high, the body stores energy efficiently. When insulin is low and ketones are elevated, fat-cell mitochondria may become more uncoupled, allowing more energy to be dissipated as heat rather than stored as fat. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) Timestamps (approximate): 01:08 — What Mitochondrial Uncoupling Means 02:18 — The Engine Analogy: Coupled vs Uncoupled 04:24 — How Mitochondria Make ATP 05:28 — Brown Fat and Heat Production 07:19 — How Scientists Measure Uncoupling 08:17 — The Type 1 Diabetes Metabolic Puzzle 11:08 — Why Insulin Lowers Energy Expenditure 13:07 — Ben’s Lab: Insulin Tightens Mitochondrial Coupling 16:59 — Ketones as the Opposite Signal 18:04 — Human Fat Biopsies and Ketone-Induced Uncoupling 20:13 — Ketosis, Brown Fat, and Energy Waste 22:39 — Calories, Hormones, and Obesity 24:49 — Low-Carb Diets and Higher Energy Expenditure 27:10 — Final Takeaways: Insulin, Ketones, and Fat-Cell Mitochondria NOTE: The information presented is not intended to be a substitute for…

    Not rated yet
  • 153: Why Amylin May Be the Most Important Weight Loss Hormone You've Never Heard Of

    · 20 min

    📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Amylin is an insulin-sparing satiety hormone released with insulin that slows digestion, restrains glucagon, and helps reduce post-meal glucose spikes. New amylin-based therapies, especially when combined with GLP-1 drugs, may offer powerful weight-loss effects by restoring natural fullness signals rather than forcing insulin higher. Summary: In this lecture, Dr. Bikman explains amylin, a hormone released from the pancreatic beta cell alongside insulin. While insulin helps move nutrients into tissues, amylin works mainly through the brain and digestive tract to increase fullness, slow gastric emptying, restrain post-meal glucagon, and reduce blood sugar spikes without forcing insulin higher. This makes amylin an insulin-sparing hormone and a natural complement to GLP-1. Ben explains why amylin was difficult to turn into a drug: human amylin naturally tends to misfold and form amyloid deposits in the pancreas. Protein engineering solved this problem by creating analogs that activate the amylin receptor without clumping. The first amylin-based drug, pramlintide, proved the concept by reducing appetite, slowing digestion, blunting post-meal glucose rises, and producing modest weight loss, though its short duration and nausea limited broader use. The lecture then moves into newer amylin-based therapies, especially cagrilintide and the combination drug CagriSema, which pairs cagrilintide with semaglutide. Because amylin and GLP-1 work through overlapping but distinct brain pathways, the combination produces greater weight loss than either hormone strategy alone. The takeaway is that amylin may become one of the most important next-generation targets in metabolic medicine because it supports satiety and glucose control without driving insulin higher. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) Timestamps (approximate): 00:44 — Intro Hook: Amylin and the Future of Weight Loss 01:46 — What Amylin Is 02:41 — Insulin and Amylin Are Released Together 03:52 — Amylin’s Effects on Satiety, Digestion, and Glucagon 04:57 — Why Amylin Is Insulin-Sparing 06:04 — Why Human Amylin Was Hard to Turn Into a Drug 10:17 — Why Pramlintide Was Limited 11:22 — Why Amylin and GLP-1 Work Well Together 12:19 — Amylin, Leptin Sensitivity, and Satiety 13:42 — Why the Combination Is Metabolically Attractive 14:48 — Cagrilintide and CagriSema 19:15 — The Next Wave of Amylin-Based Drugs 20:22 — Final Takeaways: Amylin as GLP-1’s Complement NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions. #Amylin #GLP1…

    Not rated yet
  • 152: Why Your Ketone Readings Don’t Match

    · 27 min

    📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Note: Our friends at SiBio CKM are offering a 5% discount using the code BEN5 at checkout. However, their CKM is not yet available in the United States and Canada. It is currently available in selected countries including the UK, Australia, Ireland, the Netherlands, and Germany. You can view the full list of supported countries on their website. Also, you can submit your email on their website and they will notify you when it becomes available in your region: https://www.sibiosensor.com/BEN5 Topic: Ketone testing methods differ because urine strips, breath analyzers, blood meters, and continuous ketone monitors each measure different ketone molecules or compartments. Continuous ketone monitoring offers the most useful pattern-based insight by showing how BHB changes over time in response to sleep, meals, fasting, and supplements. Summary: Ben explains the four major ways to measure ketones: urine strips, breath analyzers, finger-prick blood meters, and the newer continuous ketone monitor. He begins by reviewing the three ketone bodies produced during fat-based metabolism: acetoacetate, beta-hydroxybutyrate (BHB), and acetone. Each testing method measures a different ketone molecule, which explains why results often do not match across devices. Urine strips measure acetoacetate, making them inexpensive and useful early in a ketogenic diet, but they become less reliable as the body adapts and uses ketones more efficiently. Breath analyzers measure acetone, offering a reusable and non-invasive option, but they are vulnerable to breathing technique, alcohol, environmental compounds, and imperfect correlation with blood BHB. Blood meters measure BHB directly and remain the practical gold standard for spot-checking nutritional ketosis, but they require finger pricks and costly strips. The newest tool is the continuous ketone monitor, which measures BHB in interstitial fluid and provides hundreds of readings per day. Dr. Bikman explains that this makes it possible to see trends, overnight patterns, meal responses, supplement effects, and individual variability in a way that spot-check methods cannot capture. The practical takeaway is that continuous ketone monitoring changes the question from “What are my ketones right now?” to “How does my body respond over time?” References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) Timestamps (approximate): 01:09 — Why Ketone Testing Matters 03:13 — Acetoacetate, BHB, and Acetone 05:02 — What Each Testing Method Measures 06:04 — Urine Ketone Strips: Pros and Limits 08:09 — Why Urine Readings Change with Keto Adaptation 10:06 — Breath Ketone Analyzers and Acetone 16:44 — Continuous Ketone Monitors Explained 18:38 — Why Continuous Data Changes the Picture 24:32 — Meal Responses and Personal Variation 26:28…

    Not rated yet
  • 151: Why Retatrutide May Outperform GLP-1 Drugs

    · 26 min

    📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Retatrutide activates GLP-1, GIP, and glucagon receptors, combining appetite suppression with increased energy expenditure and powerful liver fat reduction. Dr. Bikman argues that its best use is not as a permanent shortcut, but as a tool to help people regain control over food habits and eventually reduce reliance on medication. Summary: Dr. Ben Bikman explains retatrutide, a next-generation metabolic drug that activates three receptors at once: GLP-1, GIP, and glucagon. While semaglutide targets GLP-1 and tirzepatide targets GLP-1 plus GIP, retatrutide adds a third arm through glucagon receptor activation. This makes it distinct because GLP-1 and GIP mainly reduce food intake, while glucagon adds an energy-output effect by increasing fat oxidation, liver fat clearance, and energy expenditure. Dr. Bikman focuses especially on glucagon because it is the novel feature of retatrutide. In the liver, glucagon stimulates fat burning, suppresses new fat production, promotes hepatic fat clearance, and increases energy expenditure through futile cycling and FGF21 signaling. Human trials show remarkable reductions in body weight and liver fat, with some studies reporting over 80% relative reductions in hepatic fat content and nearly 90% of treated participants reaching normal liver fat levels. He also explains that glucagon receptors are not expressed on skeletal muscle, which means the drug’s glucagon arm should not directly signal muscle breakdown. Instead, the liver and fat tissue respond while muscle largely ignores the glucagon signal. The practical takeaway is that retatrutide may represent the next major step in incretin-based therapy, but Dr. Bikman emphasizes again that these drugs should ideally be used as a temporary tool—a crutch—to help people reduce cravings, relearn eating patterns, and ultimately rely less on medication over time. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) Timestamps (approximate): 00:50 — Introduction: Retatrutide and the Next Step in Metabolic Drugs 01:49 — From Semaglutide to Tirzepatide to Retatrutide 03:15 — Why Glucagon Activation Must Be Balanced 04:15 — GLP-1 and GIP: Appetite, Cravings, and Tolerability 06:21 — Why Glucagon Is the Novel Addition 07:19 — Where Glucagon Receptors Are Found 08:24 — Hepatic Futile Cycling and Energy Expenditure 10:18 — Amino Acid Catabolism and ATP Use 12:38 — Glucagon’s Effects on Fat Cells 16:34 — Why Muscle Does Not Respond to Glucagon 18:51 — Clinical Evidence: Weight Loss and Liver Fat Reduction 20:59 — Phase 3 Results and Cardiometabolic Improvements 23:18 — Best Use Case: A Tool to Relearn Eating Patterns 25:31 — Final Takeaways: The Triple-Agonist Advantage NOTE: The information presented is not intended to be a substitute for professional medical…

    Not rated yet
  • 150: Why Tirzepatide Works Better Than GLP-1 Alone

    · 32 min

    📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Tirzepatide activates both GLP-1 and GIP receptors, producing weight loss primarily through appetite suppression, slower gastric emptying, reduced cravings, and improved insulin sensitivity—not by forcing the pancreas to make more insulin. Dr. Bikman argues that its best use may be as a temporary tool to help people regain control of food choices and lower the insulin-driving habits that caused metabolic dysfunction. Summary: In this mini-lecture, Dr. Bikman explains tirzepatide, the dual-incretin drug that activates both GLP-1 and GIP receptors. While it is often described as a drug that improves glucose by increasing insulin, Dr. Bikman argues that this explanation misses the bigger metabolic picture. He begins by reviewing the incretin effect, where oral glucose produces a stronger insulin response than the same glucose given intravenously because the gut releases hormones such as GLP-1 and GIP. GLP-1 reduces appetite, slows gastric emptying, suppresses glucagon, and helps regulate glucose, while GIP has traditionally been viewed as more fat-storing because of its actions on fat cells. Ben then resolves the “GIP paradox”: blocking GIP can cause weight loss in animals, yet activating GIP through tirzepatide also causes weight loss. The key, he argues, is insulin. GIP can amplify fat storage only when insulin is elevated, but tirzepatide lowers fasting insulin, reduces meal-related insulin demand, and reduces cravings for foods that drive insulin high. In that lower-insulin context, GIP may support healthier fat tissue function, improve adiponectin, reduce adipose hypoxia, and allow higher GLP-1 activity with better tolerability. The practical takeaway is that tirzepatide should not be viewed as a magic weight-loss injection or a permanent substitute for lifestyle change. Used wisely, it may serve as a temporary tool to reduce carbohydrate cravings, improve satiety, lower insulin demand, and help people relearn healthier eating patterns. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) Timestamps (approximate): 01:03 — Introduction: Tirzepatide and the Incretin System 02:06 — GLP-1 and GIP: The Two Incretin Hormones 04:10 — GLP-1’s Effects on Appetite, Glucagon, and Gastric Emptying 05:13 — What Tirzepatide Is 07:19 — Why Tirzepatide Is Not Simply “Raising Insulin” 08:20 — Tirzepatide Improves Insulin Sensitivity 10:54 — The Insulin-Sparing Effect 13:13 — How Tirzepatide Reduces Food Intake 15:44 — Appetite Suppression and Delayed Gastric Emptying 17:36 — The GIP Paradox 18:35 — Why Insulin Determines Whether GIP Stores Fat 22:18 — GIP’s Role in Appetite and Fat Tissue Function 25:37 — Why Dual Activation May Outperform GLP-1 Alone 29:00 — What Tirzepatide Really Does Metabolically 30:08 — Best Use Case: A Tool to Relearn…

    Not rated yet

More in Health

See all Health shows